Trials / Recruiting
RecruitingNCT07006090
EU Post-Market Registry to Collect Real-World Clinical Data on the Use of the Histolog Scanner.
A Prospective, Observational, Post-Market Registry to Collect Real-World Clinical Data on the Use of the Histolog Scanner in Multiple Disease Areas.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- SamanTree Medical SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to gather real-world evidence on the performance and safety of the Histolog® Scanner (HLS) when used as intended. HLS is a real-time ex-vivo tissue imaging device.
Conditions
- Adult Patients Undergoing a Surgery or a Medical Procedure With Use of Histolog® Scanner
- Whatever the Disease Area
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Histolog Scanner | Histolog Scanner intended to allow imaging of the internal microstructure of tissues including, but not limited to, the identification of cells, vessels and their organization or architecture. |
Timeline
- Start date
- 2026-03-04
- Primary completion
- 2036-03-01
- Completion
- 2036-04-01
- First posted
- 2025-06-05
- Last updated
- 2026-03-05
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07006090. Inclusion in this directory is not an endorsement.